Aortic Aneurysm Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global aortic aneurysm market size is likely to be valued at US$ 5.1 Bn in 2025 and is estimated to reach US$ 10.7 Bn by 2032, growing at a CAGR of 11.17% during the forecast period 2025-2032.

Market Insights

The aortic aneurysm market is expanding steadily, supported by technological advancements in stent grafts and minimally invasive surgical procedures. Rising prevalence of cardiovascular disorders and increasing geriatric population are major contributors to demand. Aortic aneurysm treatments, including endovascular aneurysm repair (EVAR) and open surgical repair (OSR), are seeing growing adoption due to improved survival rates and reduced recovery times. The growing investments in healthcare infrastructure and supportive reimbursement policies across developed regions are further accelerating market growth.

Aortic Aneurysm Market - Report Scope

The aortic aneurysm market encompasses treatment methods and medical devices used to manage thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA). Innovations in stent graft design, imaging technologies, and catheter-based interventions have transformed patient outcomes, making minimally invasive approaches a preferred treatment choice. The shift toward EVAR over OSR is a defining trend, driven by reduced hospital stays, lower complication risks, and advancements in endovascular technology.

Market Growth Drivers

Several factors are fueling the growth of the global aortic aneurysm market. Rising prevalence of hypertension, obesity, and smoking-related vascular complications is contributing significantly to aneurysm incidences. Increasing geriatric population worldwide is a key driver, as age is a major risk factor for aneurysm development. Moreover, growing awareness among patients and healthcare providers about early diagnosis and screening is enhancing procedural volumes. Favorable reimbursement frameworks and technological breakthroughs in imaging and graft design are further pushing market expansion.

Market Restraints

Despite strong growth potential, the aortic aneurysm market faces certain restraints. High treatment costs, particularly for EVAR procedures, limit accessibility in low- and middle-income regions. Lack of awareness about the severity of untreated aneurysms continues to delay diagnosis, reducing treatment opportunities. Device-related complications, such as graft leakage or migration, pose challenges to long-term outcomes. Additionally, stringent regulatory approvals for new product launches can slow down innovation cycles.

Market Opportunities

The aortic aneurysm market offers notable opportunities in both developed and emerging regions. Technological innovations such as drug-eluting stents, next-generation stent grafts, and AI-enabled imaging diagnostics are expected to transform patient management. Growing demand for minimally invasive procedures across Asia-Pacific and Latin America presents high potential for expansion. Increased healthcare spending, along with strategic collaborations between device manufacturers and hospitals, can create further market growth avenues. Additionally, the rising trend of preventive screening programs in Europe and North America supports early detection and improved treatment adoption.

Regional Outlook

• North America holds a leading share in the aortic aneurysm market, driven by advanced healthcare infrastructure, high adoption of EVAR, and supportive insurance policies in the U.S.
• Europe follows with significant demand, supported by aging population demographics, early screening programs, and strong R&D activities in stent graft technology.
• Asia Pacific is anticipated to witness the fastest growth, fueled by increasing healthcare investments in China, India, and Japan, rising patient awareness, and government support for advanced surgical procedures.
• Latin America is emerging as an attractive market, where expanding healthcare access and rising medical tourism in countries like Brazil and Mexico are contributing to demand.
• Middle East & Africa shows steady growth, supported by gradually improving healthcare infrastructure and increased awareness of cardiovascular disease management.

Leading Companies

Leading companies in the global Aortic Aneurysm Market, such as Medtronic, Endologix LLC, Gore Medical, MicroPort Scientific Corporation, Cook, JOTEC, Cardinal Health, Terumo Corporation, Lombard Medical, and AbbVie Inc., are investing in innovation and expanding their portfolios to strengthen their market positions. These players focus on developing advanced stent grafts, enhancing catheter-based treatment solutions, and forming collaborations with hospitals to broaden treatment accessibility.

Companies Covered in This Report

• Medtronic
• Endologix LLC
• Gore Medical
• MicroPort Scientific Corporation
• Cook
• JOTEC
• Cardinal Health
• Terumo Corporation
• Lombard Medical
• AbbVie Inc

Market Segmentation

By Type

• Thoracic Aortic Aneurysm (TAA)
• Abdominal Aortic Aneurysm (AAA)

By Treatment

• Open Surgical Repair (OSR)
• Endovascular Aneurysm Repair (EVAR)

By Product

• Stent Grafts
• Catheters

By End User

• Hospitals
• Ambulatory Surgery Centers
• Clinics

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

This product will be delivered within 1-3 business days.